Your browser doesn't support javascript.
loading
Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.
Wright, Eugene E; Malone, Daniel C; Trujillo, Jennifer M; Gill, Jasvinder; Huse, Samuel; Li, Xuan; Zhou, Fang Liz; Preblick, Ron; Reid, Timothy.
Afiliação
  • Wright EE; Charlotte Area Health Education Center, Charlotte, NC.
  • Malone DC; Skaggs College of Pharmacy, University of Utah, Salt Lake City.
  • Trujillo JM; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.
  • Gill J; Sanofi US, Bridgewater, NJ.
  • Huse S; Evidera, Lexington, MA.
  • Li X; Sanofi US, Bridgewater, NJ.
  • Zhou FL; Sanofi US, Bridgewater, NJ.
  • Preblick R; Sanofi US, Bridgewater, NJ.
  • Reid T; Diabetes Center at Mercyhealth System, Janesville, WI.
J Manag Care Spec Pharm ; 28(6): 592-603, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35352995

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article